Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 10/20 | 0.48 |
| ▸ | STING1 | Q86WV6 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23202739 | 1.00 | ABCB1 (0.48) | ABCB1STING1CYP3A4MAPK1PTGS1 | |
| SCHEMBL23202784 | 0.96 | ABCB1 (0.52) | ABCB1STING1CYP3A4MAPK1PTGS1 | |
| SCHEMBL30350408 | 0.96 | ABCB1 (0.52) | ABCB1STING1CYP3A4MAPK1PTGS1 | |
| SCHEMBL23202777 | 0.93 | ABCB1 (0.58) | ABCB1STING1CYP3A4MAPK1PTGS1 | |
| SCHEMBL30350414 | 0.93 | ABCB1 (0.58) | ABCB1STING1CYP3A4MAPK1PTGS1 | |
| SCHEMBL21588103 | 0.93 | ABCB1 (0.51) | ABCB1STING1CYP3A4MAPK1PTGS1 | |
| SCHEMBL23202736 | 0.90 | PTGS1 (0.49) | ABCB1STING1CYP3A4MAPK1PTGS1 | |
| SCHEMBL30350345 | 0.90 | PTGS1 (0.49) | ABCB1STING1CYP3A4MAPK1PTGS1 | |
| SCHEMBL513123 | 0.89 | ABCB1 (0.52) | ABCB1STING1CYP3A4MAPK1PTGS1 | |
| SCHEMBL30892442 | 0.89 | ABCB1 (0.52) | ABCB1STING1CYP3A4MAPK1PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110183431-B | Compound for treating or preventing liver diseases | 江苏新元素医药科技有限公司 | 2023-04-11 | — | — | CN | disclosed |